The global trauma market continues to play a central role in orthopedics, surpassing $9 billion in sales in 2024 and representing 15% of the $62 billion orthopedic market. Projections suggest steady growth ahead, with revenues expected to reach $9.4 billion in 2025 and $10.7 billion by 2028, driven by important shifts across subsegments.
Foot & Ankle: Under Pressure but Poised to Rebound
Often considered the “last gem” of orthopedics, the foot and ankle segment remains attractive at more than $5 billion in size and a high single-digit growth trajectory. Volumes slowed in 2024 and have remained under pressure in 2025, yet long-term fundamentals remain strong, and the market is expected to rebound in the coming years.
Core Trauma: Resilient and Redefined
Less dependent on elective procedures, core trauma weathered the pandemic more effectively than other orthopedic categories. Recent innovations—ranging from implant design to hospital-focused value programs—are helping streamline efficiency, expand adoption, and redefine the way providers approach trauma care.
Specialty Niches: Growth Beyond the Mainstream
Smaller but highly focused niches, including pediatric trauma and limb reconstruction, are showing significant momentum. These areas are emerging as important opportunities for growth, reflecting a broader diversification within the trauma market.
The Outlook: Stability with Upside
The trauma market is neither static nor speculative. Foot and ankle is expected to rebound, core trauma continues to be fueled by innovation, and specialty niches are carving out new pathways for expansion. Together, these dynamics point to a segment evolving steadily, balancing both resilience and opportunity.
Cosentus will continue to monitor how these trends reshape financial performance and operational strategies across the orthopedic ecosystem.
